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Abstract
Background: The amplification of RNA with the T7-System is a widely used technique for
obtaining increased amounts of RNA starting from limited material. The amplified RNA (aRNA) can
subsequently be used for microarray hybridizations, warranting sufficient signal for image analysis.
We describe here an amplification-time dependent degradation of aRNA in prolonged standard T7
amplification protocols, that results in lower average size aRNA and decreased yields.
Results: A time-dependent degradation of amplified RNA (aRNA) could be observed when using
the classical "Eberwine" T7-Amplification method. When the amplification was conducted for more
than 4 hours, the resulting aRNA showed a significantly smaller size distribution on gel
electrophoresis and a concomitant reduction of aRNA yield. The degradation of aRNA could be
correlated to the presence of the T7 RNA Polymerase in the amplification cocktail. The aRNA
degradation resulted in a strong bias in microarray hybridizations with a high coefficient of variation
and a significant reduction of signals of certain transcripts, that seem to be susceptible to this RNA
degrading activity. The time-dependent degradation of these transcripts was verified by a real-time
PCR approach.
Conclusions: It is important to perform amplifications not longer than 4 hours as there is a
characteristic 'quality vs. yield' situation for longer amplification times. When conducting
microarray hybridizations it is important not to compare results obtained with aRNA from
different amplification times.
Background
The development of microarray technology has led to a
scientific leap in research dealing with the profiling of
transcripts on a genome scale [1–4]. During the last years
it has evolved to be a powerful technique concerning bio-
logical questions involved in the transcriptional state, e.g.
oncology [5], development [6] and drug discovery [7]. In
a common microarray hybridization, two pools of RNA
(e.g. from control and treated cells) are differentially
labeled (usually by Cy3- and Cy5-labeled nucleotides)
and co-hybridized to a glass slide having either PCR prod-
ucts ("cDNA array") or gene-specific oligonucleotides
("oligo array") covalently attached to its surface. The slide
is then scanned with a confocal laser scanner and the sig-
nals corresponding to the expression state of the tran-
scripts are quantified by image analysis software.
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at least 100–200 ng mRNA or 10–20 µg total RNA, which
is equivalent to at least 107 cells or many milligrams of tis-
sue. For obtaining the required amounts of RNA from
small tissue samples derived from biopsies or single cell
isolations, techniques based either on exponential PCR
amplification [8] or isothermal linear RNA polymerase
amplification [9] have been developed. The latter is to be
preferred as RNA Polymerase activity is less prone to be
influenced by template sequence or template concentra-
tion. It has also been shown that the correlation coeffi-
cient between the RNA amplification method and a non-
amplified control is higher (i.e. less bias) than compared
to the PCR amplification technique [10].
Since the development of the RNA amplification tech-
nique, several optimizations of the amplification and
labeling process have been established, especially when
the amplified RNA (aRNA) is to be used for gene expres-
sion studies involving microarrays. The optimizations
include the use of different DNA or aRNA clean-up col-
umns after cDNA or aRNA synthesis [11], varying the
primer concentrations [12], or adjusting the template
amount and omitting second-round amplifications [13].
Very little attention has yet been focused on the effect of
the amplification time on the aRNA quality. This point
might seem marginal at first glance, because it is evident
that longer amplification times lead to more aRNA and
thus more material for hybridizations. However, we have
made the observation that prolonged (or even longer
"standard") incubation times lead to decreased aRNA
quality resulting in high-background, low-reproducible
array hybridizations. In the need to clarify the plethora of
factors leading to hybridization bias and low-quality
hybridization we found the need to address this point as
a further 'decreaser of quality' in microarray experiments.
Here we report the effect of aRNA synthesis time (amplifi-
cation time) on the quality and yield of the resulting
aRNA and the quality of the subsequent array hybridiza-
tions. We could also correlate aRNA degradation to the




Amplifications were performed from 2 to 16 hours and
separated on denaturing agarose gels (Figure 1). The deg-
radation of aRNA characterized by an incubation-time
dependent shift of the aRNA on the agarose gel towards
smaller fragments can be observed for Cy3- as well as Cy5-
labeled aRNA. Densitometric analysis of multiple gel runs
(not shown) from independent amplification reactions at
exposure times ensuring non-saturating characteristics
showed an average aRNA size distribution from 850 ± 70
nt at 2–4 hours to 430 ± 110 nt at 16 hours (n = 3).
aRNA yield
The yield of aRNA in comparison to the quality of aRNA
shows a somewhat delayed timecourse (Figure 2). The
yield increases almost linearly for the first 6 hours of
amplification, but acquires saturation characteristics at 8
hours of amplification. From that point on the yield
decreases to 16 h to an amount not more than
Incubation-time dependent degradation of aRNAFigure 1
Incubation-time dependent degradation of aRNA. 5 
µg of total RNA were amplified and labeled (either with Cy3-
UTP or Cy5-UTP) with the T7-System for 2, 4, 6, 8 and 16 
hours. The aRNA was separated on a denaturing agarose gel 
and photographed on a gel-imaging system. Fainter bands in 
the Cy5-labeled aRNA are due to quenching of Cy5-fluores-
cence by SybrGreen II and lower yield. M=Molecular weight 
marker.Page 2 of 13
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for both Cy3- and Cy5-labeled aRNA as well as for aRNA
which was not labeled with a cyanine dye ('no Dye').
RNA degrading factor
Amplification reactions were conducted with different salt
and nucleotide concentrations, and also with T7 RNA
Polymerase preparations from other vendors (data not
shown). The observations were similar to the ones
described above. Only omitting the T7 RNA Polymerase
in the amplification reaction resulted in the absence of
aRNA degrading activity (Figure 3). For this purpose, puri-
fied undegraded Cy3- and Cy5-labeled aRNA was incu-
bated 2, 8 and 16 hours in amplification cocktail lacking
the enzyme. No aRNA degradation that would have been
characterized by a shift in aRNA size distribution, was
observed. The average size of the aRNA (800 nt) is in
accordance with the 2 hour time-point in Figure 1.
Microarray hybridizations
To determine the effect of aRNA quality on the hybridiza-
tion of microarrays, we conducted hybridizations with
Cy3-labeled aRNA obtained from 4 and 16 hours of
amplification time. When comparing the signal intensi-
ties of all spots from 4 h amplification to 16 h amplifica-
tion, an overall decrease of signal intensity (37% ± 7%, n
= 3, as calculated from the sum of all intensities) was
found (Figure 4). Several 'outlier' genes can be identified
aRNA yield after different incubation timesFigure 2
aRNA yield after different incubation times. 5 µg of total RNA were amplified and labeled (either Cy3-UTP or Cy5-
UTP) or non-labeled ('no Dye' control) with the T7-System for 2, 4, 6, 8 and 16 hours (n = 3). The aRNA was purified by col-
umn chromatography and quantified by UV-spectrophotometry.Page 3 of 13
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thine guanosine phosphoribosyl transferase (HGPRT) as
two examples of transcripts, that seem to be more signifi-
cantly degraded than the majority of transcripts. A few
'outliers' can also be found in the reverse direction, indi-
cating preferential amplification compared to the major-
ity, but this shall not be discussed here, as this work is
dealing with the degradation topic. Due to the decrease in
overall signal intensity, less spots were flagged as 'present'
by the quantification software (3740 ± 322 at 16 h, com-
pared to 4820 ± 172 at 4 h), but we show here the inten-
sity of all spots. The signal intensities of triplicate
experiments show significant decrease in the signal of the
two aforementioned transcripts, when comparing 4 h
amplification and 16 h amplification (Figures 5 and 6).
To eliminate the possibility of some spatial artefact on the
slide, the signal intensities of the neighbouring spots are
also shown, revealing the signal decreasing trend, but not
to the same extend as for the two transcripts.
After normalization of signals [22], several genes gave rise
to significant signal differences between these two ampli-
fication times (Figures 7 and 8). DLP10 and HGPRT with
a signal reduction of 47-fold ± 9.9 and 8-fold ± 2.6,
respectively, are two examples of genes with a high
reproducibility of signal loss. The majority of genes (as
exemplified by the ribosomal protein S27a) were however
within the range of the normal trend of signal loss (see
above). A more extensive list of aRNA transcripts, that are
significantly affected by degradation, is shown in Table 1.
Real-time PCR
To eliminate the possibility of signal differences by "print-
ing bias", these two transcripts (and S27a as an 'unaf-
fected' gene) were subjected to real-time PCR
(Lightcycler™) after having converted the aRNA from the
different amplification time-points to cDNA (Figure 9).
Although showing different values of the degradation
ratio when compared to the array hybridizations, the
same trend applies here. The measured crossing points
(cycles needed to obtain fluorescence signals significantly
above background level) are increased at 8 h and 16 h
when compared to 4 h, which means less amplification
product (DLP: 5.6 ± 0.9 and 4.9 ± 1.2, respectively;
HGPRT: 3.7 ± 0.6 and 4.0 ± 0.5, respectively; n = 3). The
real-time PCR approach that was used for the two tran-
scripts shows significant degradation already after 8 h
amplification. Control experiments with aRNA from
equal time-points (4 h) showed little variation in signal
intensity (DLP 10: 1.8 ± 0.3; HGPRT: 1.5 ± 0.6; n = 3). The
transcript for the ribosomal protein S27a, which had been
shown to have a signal decrease within the normal trend,
only shows a slight decrease in degradation, that is not sig-
nificant (1.6 ± 0.7; n = 3).
Discussion
For a correct and reproducible analysis of the transcrip-
tome, the quality of microarray hybridizations is a crucial
point. When working with microarrays, the procedure
starting from tissue or cells ending by image analysis of
the hybridized array comprises so many steps that some
degree of intrinsic bias becomes inevitable. Many authors
have made efforts to pinpoint the sensitive steps within
this technique [10–13], optimizing the labeling, purifica-
Incubation of aRNA in the absence of T7 RNA PolymeraseFigure 3
Incubation of aRNA in the absence of T7 RNA 
Polymerase. Cy3- or Cy5-labeled aRNA that had been syn-
thesized by the optimal '4 hour protocol' was incubated 
under amplification conditions (37°C, amplification buffer) in 
the absence of T7 RNA Polymerase for 2, 8 and 16 hours. 
The aRNA was separated on a denaturing agarose gel and 
photographed on a gel-imaging system. M=Molecular weight 
marker. The slightly weaker band in Cy5 (8 h) might be due 
to small loading differences.Page 4 of 13
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components.
Many researchers having limited starting material employ
the classical T7 RNA Polymerase amplification method
developed by Eberwine and coworkers [9], either using
their own established protocols or one of the many com-
mercial kits available. By this method it is possible to
amplify starting RNA by up to 200-fold. Hybridizations
with amplified RNA compared to unamplified result in
stronger hybridization signals that meet the criteria of
significant 'signal-over-background' and thus more candi-
date genes will arise [27].
In the present study, we have focused on the effect of
amplification time on the quality of the amplified RNA.
We routinely observed low-quality, irreproducible hybrid-
ization results when our amplification protocol was
extended to longer times (>4 h), this negative effect out-
performing the increased yields of aRNA.
To clarify this phenomenon, aRNA from different ampli-
fication times was subjected to denaturing gel electro-
phoresis. A clear shift to smaller aRNA fragments was
observable when the amplification time was conducted
for more than 4 hours (Figure 1). This effect was also
irrespective of the type of cyanine dye (Cy3, Cy5) incorpo-
rated into the aRNA. Additionally to the aRNA degrada-
tion encountered at longer amplification times, there is
also a reduction in aRNA yield, but with a somewhat
delayed time-course. The interesting point to be made
here is, that a degradation of aRNA can be observed even
at time-points when there still is de novo-synthesis of
aRNA (measured by aRNA yield, Figure 2). A reduction of
aRNA yield however is only evident at very late time-
points (16 h). This observation might be based on the
concomitant synthesis of aRNA and the degradation of
Hybridization signals with aRNA from different amplification timesFigure 4
Hybridization signals with aRNA from different amplification times. Scatterplot of signal intensities (5760 features) 
from the hybridization with 4 h and 16 h amplified aRNA. The signals from the 4 h time-point were plotted in order of decreas-
ing intensity (black) with the correspoding genes from the 16 h timepoint (red). The two transcripts (DLP10 and HGPRT) 
described further are marked in circles.Page 5 of 13
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be separated by column-purification methods but which
can still be quantified spectrophotometrically. Another
possibility that cannot be ruled out is the additional syn-
thesis of smaller molecular weight transcripts by the
reduced halflife of the T7-Polymerase [16]. The degrada-
tion and reduction of yield also accounts for aRNA that
has not been labeled with a cyanine dye (Figure 2),
indicating that it is not induced by some physico-chemi-
cal property of the cyanine dyes. Thus experiments using
non-labeled aRNA should also be affected by the degrada-
tion effect.
A classical "quality vs. yield" situation is encountered
here. The degradation of aRNA shown here seems to be
the biochemical background for the observation in the
original paper from Eberwine and coworkers [9], that
amplification reactions conducted longer than 4 hours
lead to a decrease of TCA-precipitable RNA (i.e. less yield).
A more recent paper also describes an observed reduction
of aRNA yield after 5 hours of amplification [11]. The
reduced yield as shown here is a result of aRNA degrada-
tion and this is a relevant point here to be made, because
this might (and does) have an effect on post-amplification
procedures such as microarray hybridizations. Less aRNA
can be quantified when it is degraded, because the small
fragments derived from the degradation are usually lost by
column chromatography-based clean-up or precipitation
procedures, explaining why a reduction of yield can be
measured at longer amplification times. The question that
emerges here is the origin of the RNA degrading feature in
the amplification reaction.
To clarify this question, amplification reactions were con-
ducted with different salt and nucleotide concentrations,
and also with T7 RNA Polymerase preparations from
other vendors. The effect was always degraded aRNA as
described above (data not shown). Only omitting the T7
Signal intensities from triplicate hybridizations with aRNA from 4 h and 16 h amplificationFigure 5
Signal intensities from triplicate hybridizations with aRNA from 4 h and 16 h amplification. Shown is DLP10 (spot 
#11) which undergoes significant signal loss. All other signals are from neighbouring spots to eliminate DLP10 signal decrease 
due to some spatial property of the slides.Page 6 of 13
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the absence of aRNA degrading activity (Figure 3), reveal-
ing the T7 RNA Polymerase as the aRNA degrading factor.
As the aRNA in this experiment resulted from the same
cDNA as used for Figure 1, this also indicates that no other
component of the cDNA or aRNA synthesis steps are con-
tamminated by RNases.
A contamination of the T7 RNA Polymerase with RNases
would seem plausible, yet three arguments contradict this:
(i) Commercial T7 RNA preparations are usually highly
purified and tested for contamination with RNases. (ii)
The use of T7 RNA polymerase from several vendors
always resulted in the same observation, but it is unlikely
for them all to be contaminated with RNases to a similar
degree. (iii) The phenomenon of aRNA degradation is
time-dependent and not evident at the beginning of an
amplification reaction. These arguments support the
presence of an intrinsic nucleolytic activity of the T7 RNA
Polymerase, as observed also by Sastry and coworkers
[15]. This group revealed a second 3' to 5' exonuclease
activity of the T7 RNA Polymerase, which is activated in
so-called states of 'roadblock' and which results in the
exonucleolytic degradation of RNA in steps of mono- or
dinucleotides. This activity can either be induced by the
termination of the transcription reaction by reaching the
end of the template or by transcription-arresting modifi-
cations of the DNA template (i.e. psoralen-crosslink). In
the normal elongation phase the polymerase activity of
the enzyme has preference over the nuclease activity.
As seen in our experiments, the nucleolytic property of the
T7 Polymerase is present even during de novo-synthesis. It
therefore does not seem to be induced instantly after
depletion of rNTPs, but seems more likely an equilibrium
between polymerase and nuclease activity, with the direc-
tion of reaction dependent on the concentration of the
substrate rNTP. Another additional factor possibly con-
tributing to the prevailing nuclease activity after longer
Signal intensities from triplicate hybridizations with aRNA from 4 h and 16 h amplificationFigure 6
Signal intensities from triplicate hybridizations with aRNA from 4 h and 16 h amplification. Shown is HGPRT 
(spot #12) which undergoes significant signal loss. All other signals are from neighbouring spots to eliminate HGPRT signal 
decrease due to some spatial property of the slides.Page 7 of 13
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phosphate which is produced during elongation [17].
To measure the effect of aRNA from different time-points
of amplification, DNA chips containg 5760 features were
hybridized to Cy3-labeled aRNA from 4 h and 16 h
amplifications. The experimental regime of avoiding a co-
hybridization on one slide was chosen to eliminate the
effect of the differential labeling efficiency of Cy3- and
Cy5-labeled nucleotides [24]. Therefore always two slides
from the same batch with the same label (Cy3) were used.
Several genes reproducibly (n = 3) exhibited a high signal
loss (Table 1), when 4 h amplification was compared to
16 h amplification (a length that would be referred as
"overnight incubation" in some protocols). Two tran-
scripts were selected as examples for high and moderate
signal loss. DLP10 (47 ± 21%), HGPRT (8.3 ± 32%) and
S27a as an 'unaffected' transcript were further analysed by
a quantitative real-time approach (Lightcycler™) to elimi-
nate the possibility of differential signals as a result of var-
ying amounts of oligonucleotides deposited on the slide
during the printing process. The trend of signal loss for
these two transcripts could be verified, although with dif-
ferent values (DLP 16 h: 4.9 ± 1.2; HGPRT 16 h: 4.0 ± 0.5;
n = 3), which is a known phenomenon when validating
microarray hybridizations by real-time PCR [25]. With
this more sensitive approach, a significant degradation of
transcripts was measured already after 8 h of amplifica-
tion time. The 'unaffected' transcript S27a showed no sig-
nificant decrease, thus confirming the values from the
microarray hybridization.
Despite the fact of several genes mimicking a "downregu-
lation" by loss of signal intensity, some genes also
increased their signal intensity. The explanation for this
lies in the decreased overall signal intensity that we
observed, when performing hybridizations with aRNA
from different amplification times (Figure 4). The overall
signal intensity decreases due to the progressive degrada-
tion of aRNA, yet some genes seem to be affected more
and some less. Additionally, some genes seem to have a
significantly better amplification efficiency, leading to
more product than the average trend (positive outliers).
Although we think that a transcript-specific susceptibility
to the nuclease activity of the T7 RNA Polymerase might
Scatterplot of log-ratios from the hybridization signals of 4 and 16 hour amplified aRNAFigure 7
Scatterplot of log-ratios from the hybridization signals of 4 and 16 hour amplified aRNA. Ratios are displayed as a 
log2-based MA-Plot according to [14] and were transformed by locally weighted regression [22]. Spots in circles are examples 
of the two transcripts (DLP10 and HGPRT) which undergo strong time-dependent degradation.Page 8 of 13
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be investigated in more detail. There is in vivo evidence,
that besides the degradation of mRNA induced by pro-
teins binding to the untranslated regions [18], also nucle-
olytic cleavage of transripts can occur [19]. It is thus
possible that certain transcript properties dampen or
enhance the nucleolytic cleavage (degradation) by the T7
Polymerase in vitro. At this time, it is impossible for us to
condensate this phenomenon to a certain physico-chemi-
cal property of the transcripts. Although we have checked
numerous properties (GC/AT-content, local sequence
motifs, secondary structure) by bioinformatics, no com-
mon feature of these transcripts could be distilled out.
We have shown that amplification-time dependent degra-
dation of aRNA caused by the nucleolytic activity of the T7
RNA Polymerase results in strong signal bias in subse-
quent microarray hybridizations. The experimental proce-
dure conducted in our experiments uses a different
labeling protocol and different origin of RNA, but
virtually represents the self-self hybridization recently per-
formed [20]. The difference here is that we observed a
much higher coeffcient of variation (27%, n = 3), which is
based on aRNA degradation. As we have shown that aRNA
quality is dependent on the amplification time, this factor
should be taken into account when developing a standard
procedure for comparing microarray hybridizations from
different experiments. It is strongly recommended not to
compare hybridization results with aRNA obtained from
different amplification times. In the attempt to
standardize the bias-prone technique of microarray
hybridization, the international Microarray Gene Expres-
sion Data (MGED) Group has developed standards for the
Minimal Information About a Microarray Experiment
[21]. We should like to recommend, that a detailed
description of the amplification times when using ampli-
fication techniques should also be considered as standard,
since the effect on results is so significant.
Conclusions
aRNA in the classical Eberwine T7 amplification is
degraded significantly when incubation times longer than
4 hours are used. The degradation is the result of an
intrinsic nucleolytic activity of the T7 Polymerase that is
induced after longer incubation periods. Degraded aRNA
results in a strong bias in microarray hybridizations, an




RNA was isolated from testis of adult rats. Half a snap-fro-
zen (liquid nitrogen) testis was crushed under liquid
nitrogen and homogenized in 5 ml RNApure™ (Peqlab,
Germany) with an Ultra-Turrax™. Isolation of total RNA
was according to manufacturer's instructions. Total RNA
was further purified with RNeasy™ columns (Qiagen, Ger-
many), again according to manufacturer's instructions.
The integrity of total RNA was checked by denaturing for-
maldehyde/MOPS/1% agarose electrophoresis and the
purity was checked by UV-spectrophotometry in 10 mM
Na2HPO4/NaH2PO4-buffer (pH 7.0). The A260/A280-ratio
was >2.0. One pool of purified total RNA was used for all
experiments.
T7-Amplification
RNA amplification with T7 RNA Polymerase was carried
out according to the manufacturer's protocol (Ambion,
Austin, Texas) using the MessageAmp™ kit, with minor
modifications. 5 µg total RNA were annealed to 1 µl T7-
oligo-dT-primer (total volume 12 µl, 10 min, 70°C), and
reverse transcribed in a total volume of 20 µl containing 2
µl 10× first strand buffer, 1 µl ribonuclease inhibitor, 4 µl
dNTP Mix and 1 µl reverse transcriptase at 42°C for 2 hr.
Second strand synthesis was performed immediately in a
total volume of 100 µl containing the complete first-
strand reaction, 10 µl 10× second strand buffer, 4 µl dNTP
Mix, 2 µl DNA polymerase and 1 µl RNase H at 16°C for
2 hr. The reaction was digested with 1.5 µl RNase A (20
Hybridization images from the microarray features directed against the two tran c ipts from Fig. 7 and the 'unaffected' tr nscript S27aFigure 8
Hybridization images from the microarray features 
directed against the two transcripts from Fig. 7and 
the 'unaffected' transcript S27a. Circles indicate the 
degradation of the two transcripts by decrease of the signal.Page 9 of 13
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37°C and subsequently purified over cDNA purification
columns (MessageAmp™ kit). The cDNA was
concentrated to 3 µl in a vacuum centrifuge and the in-
vitro transcription (IVT) was carried out for the indicated
incubation times (2 h, 4 h, 6 h, 8 h and 16 h) at 37°C in
a reaction mixture (20 µl) containing 2 µl 10× amplifica-
tion buffer, 2 µl each ATP, CTP, GTP, UTP (75 mM each)
and 5 µl Cy3-UTP or Cy5-UTP (5 mM, Amersham Phar-
macia Biotech, Sunnyvale, CA). To decrease variability
resulting from pipetting errors, a mastermix containing all
reagents was split into aliquots for the five different exper-
imental time-points. Template DNA within the aRNA was
digested with 2 µl DNase I (10 mg/ml) at 37°C for 30
min, the aRNA purified with spin columns and stored at -
80°C.
Integrity of aRNA
The integrity of aRNA was checked by electrophoresis in a
buffer-circulating chamber system (OWL Separation Sys-
tems, USA). Aliquots (20 µl) of the IVT reaction were
denatured for 10 min at 70°C after application of one-
fourth volume of 4× RNA Loading Buffer (50% forma-
mide, 10% formaldehyde, 4× MOPS, 0.2% tartrazine as
tracking dye) and electrophoresed overnight in a 1.3%
agarose/2.2 M formaldehyde/1× MOPS gel containing
SybrGreen II (Molecular Probes, Netherlands) at 1.2 V/
cm. Gels were photographed on an imaging system
(Imago, B&L Systems, Netherlands).
aRNA yield
aRNA yield was measured spectrophotometrically with
column-purified (RNeasy™, Qiagen, Germany) aRNA in
Real-time PCR (Lightcycler™) based evaluation of the incubation time-dependent degradation of the two transcripts from Fig. 7 and S27aFigure 9
Real-time PCR (Lightcycler™) based evaluation of the incubation time-dependent degradation of the two 
transcripts from Fig. 7and S27a. aRNA from the different incubation time-points (2 h, 4 h, 8 h and 16 h) was converted to 
cDNA and equal amounts were subjected to a real-time PCR with gene-specific primers (n = 3). The presence of a single PCR 
product was confirmed by melting curve analysis (data not shown) and agarose gel electrophoresis (inset; n.T. no template 
control; M 100 bp DNA marker). Numbers in columns refer to x-fold decrease compared to 4 h, calculated by a method 
described elsewhere [23].Page 10 of 13
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spec 3000 (APBiotech, Germany) as extinction at 260 nm.
Microarray hybridization
Directly before hybridization, Cy3-labeled aRNA was frag-
mented in a total volume of 60 µl with 12 µl 5× fragmen-
tation Buffer (20 mM Tris/acetate pH 8.1, 50 mM K+-
acetate, 15 mM Mg2+-acetate) for 15 min at 94°C and
immediately put on ice. The fragmented aRNA (average
size 200–300 nt as checked by gel electrophoresis) was
purified by spin column chromatography (RNeasy™, Qia-
gen, Germany) and concentrated to 3–5 µl in a vacuum
centrifuge. 40 µl of QMT™ Hybridization Buffer (Quanti-
foil, Jena, Germany) were applied to the concentrated
aRNA. Commercial oligo-based microarray slides (Pan™
Rat 5 K, MWG-Biotech, Germany) were pre-blocked in
QMT™ Blocking Solution (Quantifoil, Germany) at 50°C
for 4 h. The hybridization mixture was incubated at 90°C
for 3 min and immediately put on ice. Hybridization was
performed under a glass cover-slip in a standard microar-
ray hybridization chamber (MWG-Biotech, Germany) at
42°C for 16 h. The slides were washed at room tempera-
ture for 10 min each in 2× SSC/0.05% NP-40, 1× SSC/
0.05% NP-40, 0.2× SSC/0.05% NP-40 and spun (200 g, 2
min) to dryness. Hybridizations were conducted in
triplicate with slides from the same production batch to
minimize printing bias. The slides were scanned on an
Affymetrix 428™ Array Scanner (Affymetrix, Santa Clara,
CA) at photomultiplier setting 'gain 60' and analysed with
the Phoretix™ Array software (Nonlinear Dynamics, Dur-
ham, NC).
The degradation ratio was calculated as
, as deduced from  and
M being , as described in [14]. Parentheses
indicate s.d. in %.
Statistical significance between these two time-points
were calculated by penalized t-statistics according to [26],
which uses the 90th percentile of the standard deviations
from all spots as an empirical correction factor.
Table 1: Characteristics of the most prominent genes affected by aRNA degradation. Compilation of genes, that are significantly (p < 
0.05) subjected to aRNA degradation when 4 hour incubations are compared to 16 hour (n = 3). Table lists the name of the transcripts, 
descending in the order of the degradation ratio, GenBank accession numbers, transcript size and p-values of the penalized t-statistic 
as described in [26]. (p. only partial cDNA sequences available at GenBank).
Transcript name Ratio Accession # length p-value
dynein-like protein 10 47 ± 21% D26502 354 p. 0.0144
integrin beta-1 subunit 12.5 ± 27% NM_017022 2894 0.0234
tcr delta 11.1 ± 17% AF259789 359 p. 0.0095
rat hypoxanthine-guanine phosphoribosyltransferase 8.3 ± 32% S79292 853 0.0325
cd44 protein 8.1 ± 23% U96138 4038 0.0172
lyn protein non-receptor kinase 6.7 ± 21% NM_030857 3438 0.0141
cyclic nucleotide phosphodiesterase 5.1 ± 19% NM_022710 1831 0.0188
tuberin-like protein 5.0 ± 24% NM_020083 4258 0.0187
2'5' oligoadenylate synthetase-2 4.8 ± 29% AF068268 2371 0.0269
dopamine d2 receptor rgb-2 4.3 ± 15% NM_012547 2750 0.0074
rolipram-insensitive phosphodiesterase type 7 4.2 ± 17% U77880 2870 0.0095
mip protein 261 4.0 ± 22% X53052 936 p. 0.0158
rin1 3.7 ± 32% U80076 2548 0.0325
mitogen activated protein kinase kinase kinase 3.7 ± 21% NM_013055 3754 0.0212
immunoglobulin kappa-chain igkv 3.4 ± 29% L07406 381 p. 0.0269
rat heart-derived proto-oncogene 3.3 ± 17% NM_012784 7902 0.0091
rab27b, member ras oncogene family rab27b 3.2 ± 27% NM_053459 890 0.0234
steroid sensitive gene-1 protein 3.1 ± 31% NM_022543 3719 0.0306
matrix metalloproteinase 24 3.1 ± 21% NM_031757 4245 0.0104
flotillin 2 3.0 ± 26% NM_031830 2629 0.0218
calcium-independent alpha-latrotoxin receptor 3.0 ± 25% NM_022962 5579 0.0202
neurotrypsin nt 2.9 ± 28% AJ311671 2499 p. 0.0252
tenascin 2.9 ± 22% U09361 1727 p. 0.0151
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2 µg of purified aRNA from the different amplification
time-points were converted to cDNA in a total volume of
20 µl containing 500 ng random hexamers (Promega,
Madison, WI), 5× first strand buffer (Invitrogen, Carlsbad,
CA), 2 µl 0.1 M DTT, 1 µl dNTP Mix (10 mM each, Sigma,
Deisenhofen, Germany) and 1 µl Superscript™ II reverse
transcriptase (Invitrogen, Carlsbad, CA) for 90 min at
42°C. The first-strand reaction was diluted to 100 µl and
2 µl were used for a subsequent real-time PCR in a Light-
cycler™ instrument (Roche, Basel, Switzerland) using a
home-made PCR cocktail containing 10 pmol each gene
specific primers, 2 µl dNTP mix (25 mM each, Takara Bio,
Shiga, Japan), 0.5 µl SybrGreen I (1:1000 in DMSO;
Molecular Probes, Leiden, Netherlands), 2.75 mM MgCl2,
2 µl BSA (10 mg/ml; New England Biolabs, Beverly, MA)
and 0.2 µl Ex-Taq HS (5 U/µl; Takara Bio, Shiga, Japan) in
a total volume of 20 µl. Gene specific primers used were
DLP10 sense: caccaaggacctcgccaaag, DLP10 antisense:
agctggtggatcagcgcatt (product size 213 bp, position 87–
299 of GenBank D26502); HGPRT sense:
cgaccggttctgtcatgtcg, HGPRT antisense: gcacacagag-
ggccacaatg (product size 216 bp, position 146–361 of
GenBank XM_343829); S27a sense: ccaggataaggaaggaattc-
ctcctg, S27a antisense: ccagcaccacattcatcagaagg (product
size 296 bp, position 132–428 of GenBank NM_031113).
An initial denaturation was conducted for 3 min at 95°C
to activate the enzyme. 30 cycles of amplification were
performed with a denaturation at 95°C for 30 s,
annealing at primerspecific temperatures (DLP10: 68°C;
HGPRT: 65°C; S27a: 60°C) for 10 s, elongation at 72°C
for 30 s, followed by a fluorescent data acquisition after
20 s at 80°C. Following the cycling program, a melting
curve was performed by cooling to 40°C for 2 min and
then increasing the temperature to 95°C with a slope of
0.2°C/s while measuring the fluorescence continuously.
The melting peak was obtained by plotting the negative
first derivate of fluorescence against temperature. The
threshold cycle (crossing point) in which the fluorescence
rises significantly above background level was determined
by a second derivate maximum method with the use of
the LightCycler™ quantification software. Fold-differences
were calculated by a mathematical model described by
Pfaffl [23]. In addition to the verification of a single PCR
product by the presence of only one melting peak, the
PCR cocktail was spun out of the glass capillaries (2000 g,
1 min) and resolved by electrophoresis on a 1.3% agar-
ose/TAE gel. Gels were imaged with the Imago System
(B&L Systems, Netherlands).
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